It also disrupts sleep and lowers dietary inhibition, both of which indirectly undermine treatment
Most patients lose 15 pounds in 8 to 16 weeks on GLP-1 medications Tirzepatide may produce slightly faster results than Semaglutide Appetite suppression often begins within the first 12 weeks Healthy weight loss averages 1 to 2.5 pounds per week Results depend on dosing, nutrition, activity, and consistency GLP-1 medications such as Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro) are widely used in medical weight loss programs to help reduce appetite and support gradual fat loss
The FDA warning did not specifically involve NAION or vision loss risks
Biomedicine and Pharmacotherapy , 120
This increased medical attention could lead to a higher likelihood of their eye problems being detected and treated, which is what the study measured, creating the appearance of increased risk. Thirdly, the actual events were very small less than 0.2% so despite statistical adjustment results may not be accurate, he added
Moreover, GLP-1 could down-regulate ANG II production at tissue level (71) indeed reported that chronic treatment with GLP-1RA exendin 4 (Ex4) in rats decreased renal cortical ANG II content and urinary excretion of AGT, while blockade of GLP-1 receptor with exendin 9 (Ex9) exerted opposite effects